DIA
Drug Information Association Logo
« Back to Listing

FDA Enforcement Update: Advertising and Promotion

Track:
Regulation of Product Advertising and Marketing in an Ever-changing World

Day & Time:
June 17, 1:30PM - 3:00PM (Pacific Standard Time)

Session Number:
261

Room Number:
7A

Level:
Intermediate

Type:
Forum

Title:
FDA Enforcement Update: Advertising and Promotion

Chair(s):
Janet "Lucy" Rose, MBA
President
Lucy Rose and Associates, LLC, United States

Description:
FDA enforcement actions and policy guidances need to be understood by every company because they reflect FDA's priorities and concerns in regulating advertising and promotion. In this forum, an FDA professional and a representative from industry will examine the latest agency enforcement actions and policies and what they mean.

Learning Objective(s):
Describe the latest FDA enforcement actions and policy initiatives in the area of advertising and promotion; Explain what the enforcement actions reflect about FDA policies and priorities.

Presentation(s) & Speaker(s):
CDER Perspective
Thomas W. Abrams, MBA, RPh
Director, Office of Prescription Drug Promotion, CDER
FDA, United States

CBER Perspective
Lisa L. Stockbridge, PhD
Branch Chief, Advertising and Promotional Labeling Branch, CBER
FDA, United States